Grant name: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding organization: National Institutes of Health (NIH)
Total funding amount: $225,000 per year, $450,000 over 3 years
Primary objective: Support formative research and pilot-testing of interventions targeting HIV prevention and treatment outcomes.
Key stakeholders: NIMH, community-based organizations, researchers, and individuals affected by HIV.
Funding source: NIH.
Significance: Addresses critical barriers in HIV prevention and treatment.
Grant frequency: Recurring.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Governments
U.S. Territory or Possession
Other: Independent School Districts, Public Housing Authorities, Faith-based Organizations, Regional Organizations, Foreign Institutions.
Organizations must complete registrations with SAM, eRA Commons, and Grants.gov prior to application submission.
All PD(s)/PI(s) must have an eRA Commons account.
HIV prevention and treatment outcomes.
Implementation science approaches.
Feasibility, acceptability, and safety of interventions.
Improved HIV prevention and treatment outcomes.
Research teams are encouraged to include community members and relevant organizations.
Direct costs limited to $225,000 per year.
Total project period may not exceed three years.
Application due dates extend until January 9, 2026.
Must comply with NIH Grants Policy Statement.
Applications must be submitted electronically via Grants.gov.
Follow instructions in the SF424 (R&R) Application Guide.